US equities |
NVDA $239.68 ▲+2.45% SPCX $169.69 ▲+6.75% MU $1,062.08 ▼-1.19% TSLA $379.78 ▲+2.48% SNDK $1,701.10 ▼-1.10% MSFT $528.89 ▲+2.20% INTC $116.30 ▼-2.54% META $743.79 ▲+2.16%
FinancialContent

Latest News about NASDAQ:TNXP

Recent news which mentions NASDAQ:TNXP

AI Security, “Netflix of China”, Healthcare Breakthroughs, Pure Play on $31 Billion Watch Market: iQIYI, TNXP, REGRF, AITX; Leaders Report Latest Advances
Tickers AITX IQ NEWS REGRF
Tags NASDAQ:IQ OTC:REGRF CSE:NEWS
From News Direct
TNXP Stock Earnings: Tonix Pharmaceuticals Misses EPS, Misses Revenue for Q2 2024
Tickers TNXP
Tags Market News TNXP Earnings Reports
From InvestorPlace
Tonix Pharmaceuticals Awarded potential 34 million dollar Contract with U.S. Department of Defence
Tags NASDAQ:TNXP
From News Direct
Tonix Pharmaceuticals receives positive feedback from FDA on Tonmya™ for fibromyalgia management
Tickers TNXP
Tags NASDAQ:TNXP
From News Direct
Tonix Pharmaceuticals Nears Market Entry with Tonmya for Fibromyalgia Management
Tags NASDAQ:TNXP
From News Direct
TNXP Stock Earnings: Tonix Pharmaceuticals Beats EPS, Misses Revenue for Q1 2024
Tickers TNXP
Tags Market News TNXP Earnings Reports
From InvestorPlace
TNXP Stock Earnings: Tonix Pharmaceuticals Beats EPS, Misses Revenue for Q4 2023
Tickers TNXP
Tags Market News Earnings Reports TNXP
From InvestorPlace
Tonix Pharmaceuticals drug TNX-102 SL gets FDA ok for US Department of Defense funded trial
Tags NASDAQ:TNXP
From News Direct
Tonix Pharmaceuticals' Fibromyalgia Trial Shows Promising Results in Webinar Presentation
Tags NASDAQ:TNXP
From News Direct
Tonix Pharmaceuticals announces key topline data from 2nd Phase 3 Clinical Trial of TNX-102 SL
Tags NASDAQ:TNXP
From News Direct
Tonix Pharmaceuticals shared details of IND clearance for Phase 2 trial of TNX-2900
Tags NASDAQ:TNXP
From News Direct
Tonix Pharmaceuticals' CEO reveals next-generation COVID vaccine technology chosen for key program
Tags NASDAQ:TNXP
From News Direct
Tonix Pharmaceuticals finish Phase 3 trial of TNX-102 SL for management of Fibromyalgia
Tags NASDAQ:TNXP
From News Direct
Tonix Pharmaceuticals releases positive results from Proof-Of-Concept Study on TNX-102 SL
Tags NASDAQ:TNXP
From News Direct
Tonix Pharmaceuticals begins Phase 1 trial of TNX-1500 in healthy participants
Tags NASDAQ:TNXP
From News Direct
Tonix Pharmaceuticals begins Phase 1 trial of TNX-1500 in healthy participants
Tags NASDAQ:TNXP
From News Direct
Tonix Pharmaceuticals fibromyalgia study published in American College of Rheumatology
Tags NASDAQ:TNXP
From News Direct
Tonix Pharmaceuticals shares breakthrough of TNX-601 ER study on patients with depression
Tags NASDAQ:TNXP
From News Direct
Tonix Pharmaceuticals TNX-1500 monoclonal antibody published in American Journal of Transplantation
Tags NASDAQ:TNXP
From News Direct
Tonix Pharmaceuticals announces acquisition of Healion Bio antiviral portfolio
Tags NASDAQ:TNXP
From News Direct
Tonix Pharmaceuticals discusses exclusive license of potential monoclonal antibodies
Tags NASDAQ:TNXP
From News Direct
Tonix CEO Calls for New Class of Covid-19 Pre-Exposure and Therapeutic Antibodies for High-Risk Populations
Tickers TNXP
Tags NASDAQ:TNXP
From News Direct
Why Is Tonix Pharmaceuticals (TNXP) Stock Up 40% Today?
Tickers TNXP
Tags TNXP NASDAQ:TNXP Market News
From InvestorPlace
Tonix Pharmaceuticals (TNXP) Stock Surges 15% on Patent News
Tickers TNXP
Tags Today's Market NASDAQ:TNXP TNXP
From InvestorPlace
Why Is Tonix Pharmaceuticals (TNXP) Stock Up 30% Today?
Tickers TNXP
Tags Market News TNXP NASDAQ:TNXP
From InvestorPlace
TNXP Stock Forecast: 12-month Price Target of $2.63 (Updated March 2022)
Tickers TNXP
Tags News TNXP Stock NASDAQ:TNXP
From Best Stocks
Tonix Pharmaceuticals Stock Belongs in the Biotech Dustbin
Tickers TNXP
Tags Market News Penny Stocks TNXP
From InvestorPlace
Why Is Tonix Pharmaceuticals (TNXP) Stock Up Today?
Tickers TNXP
Tags Today's Market Market News TNXP
From InvestorPlace
TNXP Stock Alert: The Migraine News Sending Tonix Pharmaceuticals Soaring
Tickers TNXP
Tags Today's Market Market News TNXP
From InvestorPlace